These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 29524148

  • 1. Establishment of Cell Lines Stably Expressing dCas9-Fusions to Address Kinetics of Epigenetic Editing.
    Goubert D, Koncz M, Kiss A, Rots MG.
    Methods Mol Biol; 2018; 1767():395-415. PubMed ID: 29524148
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Protocol for Allele-Specific Epigenome Editing Using CRISPR/dCas9.
    Rajaram N, Bashtrykov P, Jeltsch A.
    Methods Mol Biol; 2024; 2842():179-192. PubMed ID: 39012596
    [Abstract] [Full Text] [Related]

  • 6. Plasmid Delivery and Single-Cell Plasmid Expression Analysis for CRISPR/dCas9-Based Epigenetic Editing.
    van den Berg van Saparoea ACH, van Loosen QC, Sarno F, Ntini E, Rots MG, Gjaltema RAF, Verschure PJ.
    Methods Mol Biol; 2024; 2842():255-265. PubMed ID: 39012600
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Targeting cancer epigenetics with CRISPR-dCAS9: Principles and prospects.
    Rahman MM, Tollefsbol TO.
    Methods; 2021 Mar; 187():77-91. PubMed ID: 32315755
    [Abstract] [Full Text] [Related]

  • 9. Harnessing CRISPR-Cas9 for Epigenetic Engineering.
    Guerra-Resendez RS, Hilton IB.
    Methods Mol Biol; 2022 Mar; 2518():237-251. PubMed ID: 35666449
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A review on CRISPR/Cas-based epigenetic regulation in plants.
    Jogam P, Sandhya D, Alok A, Peddaboina V, Allini VR, Zhang B.
    Int J Biol Macromol; 2022 Oct 31; 219():1261-1271. PubMed ID: 36057300
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CRISPR-based epigenome editing: mechanisms and applications.
    Fadul SM, Arshad A, Mehmood R.
    Epigenomics; 2023 Nov 31; 15(21):1137-1155. PubMed ID: 37990877
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Targeted Modification of Epigenetic Marks Using CRISPR/dCas9-SunTag-Based Modular Epigenetic Toolkit.
    Song MK, Kim YS.
    Methods Mol Biol; 2024 Nov 31; 2761():81-91. PubMed ID: 38427231
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
    Okada M, Kanamori M, Someya K, Nakatsukasa H, Yoshimura A.
    Epigenetics Chromatin; 2017 Nov 31; 10():24. PubMed ID: 28503202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.